Home » Topics » Regulatory » Health Canada

Health Canada
RSS

TONIX reports encouraging pharmacokinetic data on TNX-102

July 10, 2012

Health Canada approves Jakavi for treatment of patients with myelofibrosis

July 6, 2012

Optimer obtains approval in Canada for CDI treatment

July 6, 2012

Theratechnologies gives update on tesamorelin regulatory progress

June 25, 2012

Sunovion reports Canadian approval of once-daily schizophrenia therapy

June 18, 2012

Label update approved for Tysabri to include anti-JC virus antibody status

May 24, 2012

Seattle Genetics' Adcetris NDS accepted for review by Health Canada

May 24, 2012

Health Canada grants Apricus Biosciences meeting for nail fungus therapy

May 14, 2012

Apricus Biosciences to meet with Health Canada on Femprox

May 9, 2012

Boston Scientific stent system set for launch in Canada

April 26, 2012

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...